Predicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers
Chronic urticaria (CU) is characterised by intense recurrent itch, wheals, and/or angioedema, persisting for >6 weeks. CU can be subdivided into chronic spontaneous urticaria and chronic inducible urticaria; the latter usually appears with physical stimuli, such as heat, cold, pressure, and sunli...
Saved in:
Main Authors: | Misbah Noshela Ghazanfar (Author), Simon Francis Thomsen (Author) |
---|---|
Format: | Book |
Published: |
European Medical Journal,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
by: Misbah Nasheela Ghazanfar, et al.
Published: (2015) -
Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
by: Ilya Ivyanskiy, et al.
Published: (2012) -
Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib
by: Diamond R. Guy, BS, et al.
Published: (2024) -
The use of an urticaria control test for the evaluation of omalizumab treatment response in patients diagnosed with chronic urticaria
by: Burhan Engin, et al.
Published: (2020) -
Omalizumab in treatment-resistant chronic spontaneous urticaria
by: Kiran V Godse
Published: (2011)